Telmisartan+Amlodipine Fixed Dose Combination in Hypertension

Summary

The primary objectives of this trial is to evaluate the changes from baseline (Visit 2) in the 24-hour Ambulatory Blood Pressure Monitoring mean (relative to dose time) for diastolic blood pressure and systolic blood pressure after 8 weeks of treatment with Telmisartan 80mg/Amlodipine 5mg in patients with moderate to severe hypertension

Timeline

Start

2010-11

Primary completion

2011-07

Completion

—

Drugs

Indications